Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.
about
International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease statesPhosphorylation-mediated regulation of GEFs for RhoAInsights into bombesin receptors and ligands: Highlighting recent advancesAutomated NMR fragment based screening identified a novel interface blocker to the LARG/RhoA complexAnalysis of the transcriptomes downstream of Eyeless and the Hedgehog, Decapentaplegic and Notch signaling pathways in Drosophila melanogasterHigh-throughput screening for small-molecule inhibitors of LARG-stimulated RhoA nucleotide binding via a novel fluorescence polarization assayNeural regulation of hematopoiesis, inflammation, and cancer.Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells.ROCK1 feedback regulation of the upstream small GTPase RhoAGastrin-releasing peptide receptor in breast cancer mediates cellular migration and interleukin-8 expression.Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.The Rho-guanine nucleotide exchange factor PDZ-RhoGEF governs susceptibility to diet-induced obesity and type 2 diabetes.High RhoA expression at the tumor front in clinically localized prostate cancer and association with poor tumor differentiation.Glucocorticoid receptor-mediated expression of caldesmon regulates cell migration via the reorganization of the actin cytoskeleton.PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.Possible involvement of CD10 in the development of endometriosis due to its inhibitory effects on CD44-dependent cell adhesion.A novel role for p115RhoGEF in regulation of epithelial plasticity.Integrin signaling aberrations in prostate cancer.Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer.Connecting myelin-related and synaptic dysfunction in schizophrenia with SNP-rich gene expression hubs.Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays.Mitotic-dependent phosphorylation of leukemia-associated RhoGEF (LARG) by Cdk1.Gα13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration.Androgen receptor-target genes in african american prostate cancer disparities.CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
P2860
Q24643524-858421D4-5EB7-4E7F-A4FB-14A925E78A8DQ26823650-A01175A5-02E9-452B-BEA0-9E93C7A232C8Q28081153-EFD25164-52A3-43CE-8C84-694EA2361744Q28539542-47327CC7-987F-4AD2-A7C8-167D3336BBFFQ31089432-7D1B93F4-6292-466B-865D-7E82F8A02C0BQ33406057-477AF953-0D2C-4F85-A854-C02D1B12293BQ35560457-E57C99B5-1598-48F3-86F7-0F7C5B1E0CF9Q35646098-6CC166A6-C3EA-4535-A45E-FA2D0F207C3CQ35911375-56EF8468-CD5D-4DD0-B436-CC39657305AFQ36067344-CF1D3FAD-29D9-44FE-ABAB-F6E34FDEE1A1Q36106835-BF4AA593-EA2E-4DCB-81D8-2568EABC6603Q36452423-B89658FD-B584-4FBC-A9EC-743CFA560224Q36524695-2B14C07A-3E79-4ABF-9899-2884101813AAQ37142731-F90D12AA-2670-4B83-ADFA-16545C9E2C07Q37201511-662A9D38-5DF9-417A-B429-41EA8679D52DQ37379796-D4F6BE09-2F9B-4355-9F76-F5C910EB4E1AQ37509707-CA6358C6-7797-49E1-B04D-F794C799939FQ37643449-0227A938-CB3F-4880-B627-D4FAD9ECF4AEQ37855740-2B1667EA-00B2-4334-ACC0-2E24B235E710Q38850829-BA2FA721-B5EE-4604-A302-22B8AF568768Q39899689-FB808056-8A70-4546-925B-B9F45C3AAF22Q40368919-59F4A522-19F6-452F-941C-1DDEF9C1076EQ40408281-F62ECEEA-1CA5-47B8-A276-8C70174240C9Q40413517-75E9AD11-D731-4D35-9C54-A41A1D4796C5Q41821246-C251759B-054D-4DE4-B8F9-2F21FD30F857Q42261015-38AE1A6A-35D0-4515-97C1-EB588E88FEB2Q54205206-557CAED8-45C6-4C8C-AB0A-C0871D7F11AF
P2860
Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Neuropeptide-stimulated cell m ...... ited by neutral endopeptidase.
@en
type
label
Neuropeptide-stimulated cell m ...... ited by neutral endopeptidase.
@en
prefLabel
Neuropeptide-stimulated cell m ...... ited by neutral endopeptidase.
@en
P2093
P2860
P356
P1433
P1476
Neuropeptide-stimulated cell m ...... ited by neutral endopeptidase.
@en
P2093
Goodman OB Jr
Sugimoto N
P2860
P2888
P304
P356
10.1038/SJ.ONC.1209586
P407
P577
2006-05-01T00:00:00Z
P5875
P6179
1050678168